OBJECTIVE: To examine the patterns of antituberculous drug resistance of Mycobacterium tuberculosis in patients with pulmonary and extra-pulmonary tuberculosis in the Eastern province of the Kingdom of Saudi Arabia. METHODS: This is a retrospective study of antibiotic susceptibility of 1681 non-repetitive M. tuberculosis isolates from 1/2003 to 6/2010. RESULTS: Of the total patients, 41% (n=687) were Saudis and 59% (n=994) were non-Saudis. The pulmonary and extra-pulmonary specimens constituted 68% (n=1148) and 32% (n=533), respectively. The incidence of resistance was 15.5% to one or more of anti-tuberculosis drugs. The resistance rates to first-line drugs were as follows: streptomycin (10.4%), INH (9.8%), rifampicin (1.5%) and ethambutol (1.0%). Multi-drug resistant tuberculosis was present in 1.4% (n=24) of the sample. CONCLUSION: INH resistance in this study was relatively high, whereas the rate of MDR-TB was low. A rate of MDR-TB observed in this study was 1.4%. Thus, an empiric four-drug therapy is required to treat patients with tuberculosis in this area of Saudi Arabia.
OBJECTIVE: To examine the patterns of antituberculous drug resistance of Mycobacterium tuberculosis in patients with pulmonary and extra-pulmonary tuberculosis in the Eastern province of the Kingdom of Saudi Arabia. METHODS: This is a retrospective study of antibiotic susceptibility of 1681 non-repetitive M. tuberculosis isolates from 1/2003 to 6/2010. RESULTS: Of the total patients, 41% (n=687) were Saudis and 59% (n=994) were non-Saudis. The pulmonary and extra-pulmonary specimens constituted 68% (n=1148) and 32% (n=533), respectively. The incidence of resistance was 15.5% to one or more of anti-tuberculosis drugs. The resistance rates to first-line drugs were as follows: streptomycin (10.4%), INH (9.8%), rifampicin (1.5%) and ethambutol (1.0%). Multi-drug resistant tuberculosis was present in 1.4% (n=24) of the sample. CONCLUSION: INH resistance in this study was relatively high, whereas the rate of MDR-TB was low. A rate of MDR-TB observed in this study was 1.4%. Thus, an empiric four-drug therapy is required to treat patients with tuberculosis in this area of Saudi Arabia.
Keywords:
DST; Eastern Saudi Arabia; Incidence; MDR-TB; NTBCP; Prevalence; Resistance; SDR-TB; Tuberculosis; drug sensitivity test; multi-drug resistance tuberculosis; national tuberculosis control program; single drug resistance tuberculosis
Authors: J Francis Borgio; Alia Saeed Rasdan; Bayan Sonbol; Galyah Alhamid; Noor B Almandil; Sayed AbdulAzeez Journal: Biology (Basel) Date: 2021-11-06
Authors: Khalifa M Binkhamis; Mohammed A Bahatheg; Faisal A Altahan; Saleh S Alwakeel; Khalid A Almutairi; Abdullah F Alsaeed; Dalal A Alkadi; Hanan A Alshafai; Fahad M Almajid; Mazin A Barry Journal: Saudi Med J Date: 2021-06 Impact factor: 1.422
Authors: Maha Al Ammari; Abdulrahman Al Turaiki; Mohammed Al Essa; Abdulhameed M Kashkary; Sara A Eltigani; Anwar E Ahmed Journal: Antimicrob Resist Infect Control Date: 2018-01-22 Impact factor: 4.887
Authors: Mohammed S Al-Shahrani; Majed I Hakami; Mahmoud A Younis; Hanan A Fan; Mohammed A Jeraiby; Yasser Alraey Journal: Saudi Med J Date: 2021-07 Impact factor: 1.422